During this Conference, Valentín Ceña presented line of action 5 at the University of Castilla-La Mancha: “Pharmacological characterization of nanoparticles” in collaboration with the Singular Center for Research in Molecular Medicine and Chronic Diseases (USC) and CICbioGUNE focused on treatment of glioblastoma with nanoparticles.